David S. Duch

3.0k total citations · 2 hit papers
62 papers, 2.6k citations indexed

About

David S. Duch is a scholar working on Molecular Biology, Organic Chemistry and Clinical Biochemistry. According to data from OpenAlex, David S. Duch has authored 62 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 14 papers in Organic Chemistry and 14 papers in Clinical Biochemistry. Recurrent topics in David S. Duch's work include Biochemical and Molecular Research (17 papers), Metabolism and Genetic Disorders (14 papers) and Amino Acid Enzymes and Metabolism (11 papers). David S. Duch is often cited by papers focused on Biochemical and Molecular Research (17 papers), Metabolism and Genetic Disorders (14 papers) and Amino Acid Enzymes and Metabolism (11 papers). David S. Duch collaborates with scholars based in United States, United Kingdom and Chile. David S. Duch's co-authors include Charles A. Nichol, Mark Edelstein, Gary K. Smith, Yoshisuke Ozaki, E. M. GRIVSKY, Carl W. Sigel, Shuliang Lee, Gail K. Smith, Robert Ferone and Norman Kirshner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Annual Review of Biochemistry.

In The Last Decade

David S. Duch

62 papers receiving 2.5k citations

Hit Papers

BIOSYNTHESIS AND METABOLISM OF TETRAHYDROBIOPTERIN AND MO... 1980 2026 1995 2010 1985 1980 100 200 300 400

Peers

David S. Duch
Comparison fields: 5 of 112
  • Molecular Biology 1.2k
  • Organic Chemistry 548
  • Clinical Biochemistry 461
  • Physiology 342
  • Biological Psychiatry 311
Camilo Rojas United States
Johan Palmfeldt Denmark
Joseph B. Monahan United States
Ramesh Kekuda United States
Federico Da Settimo Italy
T. Phillip Waalkes United States
Robert Silber United States
You-Jun Fei United States
June R. Aprille United States
Sabrina Taliani Italy
Camilo Rojas United States View profile →
Citations per field, relative to David S. Duch
David S. Duch · 1×
Citations per year, relative to David S. Duch
David S. Duch · 1×

Countries citing papers authored by David S. Duch

Since Specialization
Citations

This map shows the geographic impact of David S. Duch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David S. Duch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David S. Duch more than expected).

Fields of papers citing papers by David S. Duch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David S. Duch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David S. Duch. The network helps show where David S. Duch may publish in the future.

Co-authorship network of co-authors of David S. Duch

This figure shows the co-authorship network connecting the top 25 collaborators of David S. Duch. A scholar is included among the top collaborators of David S. Duch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David S. Duch. David S. Duch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Synchronization of cells in the S phase of the cell cycle by 3?-azido-3?-deoxythymidine: implications for cell cytotoxicity Cancer Chemotherapy and Pharmacology B. Chandrasekaran, Timothy E. Kute et al. 20
2 Thienyl and Thiazolyl Acyclic Analogs of 5-Deazatetrahydrofolic Acid Journal of Medicinal Chemistry Eric C. Bigham, David S. Duch et al. 5
3 Effect of purine synthesis inhibition on WiDr spheroids in vitro or on WiDr or colon 38 tumors in vivo Biochemical Pharmacology Marilyn Jansen, Michael Dykstra et al. 7
4 Benzoquinazoline inhibitors of thymidylate synthase: enzyme inhibitory activity and cytotoxicity of some 3-amino- and 3-methylbenzo[f]quinazolin-1(2H)-ones Journal of Medicinal Chemistry William Pendergast, Scott H. Dickerson et al. 45
5 Synthesis and biological activity of open-chain analogs of 5,6,7,8-tetrahydrofolic acid-potential antitumor agents Journal of Medicinal Chemistry Eric C. Bigham, David J. Wilson et al. 26
6 A Comparison of Hplc and Ternary Complex-Based Assays of Tissue Reduced Folates Analytical Letters David G. Priest, Marlene A. Bunni et al. 5
7 Studies on the mechanism of antitumor action of 2-desamino-2-methyl-5,8-dideazaisofolic acid Biochemical Pharmacology David S. Duch, Mary H. Hanlon et al. 13
8 Preparation of a chiral matrix Journal of Chromatography A Robert J. Mullin, David S. Duch 3
9 The Role of Tryptophan and Kynurenine Transport in the Catabolism of Tryptophan Through Indoleamine 2,3-Dioxygenase Advances in experimental medicine and biology Richard G. Knowles, C I Pogson et al. 6
10 Folate analogs. 35. Synthesis and biological evaluation of 1-deaza, 3-deaza, and bridge-elongated analogs of N10-propargyl-5,8-dideazafolic acid Journal of Medicinal Chemistry Muraleedharan G. Nair, Roy L. Kisliuk et al. 59
11 Synthesis and biological activity of an acyclic analog of 5,6,7,8-tetrahydrofolic acid, N-[4-[[3-(2,4-diamino-1,6-dihydro-6-oxo-5-pyrimidinyl)propyl]amino]benzoyl]-L-glutamic acid Journal of Medicinal Chemistry James L. Kelley, Ed W. McLean et al. 24
12 Activity of an NAD-dependent 5,10-methylenetetrahydrofolate dehydrogenase in normal tissue, neoplastic cells, and oncogene-transformed cells Archives of Biochemistry and Biophysics Gary K. Smith, Thomas J. Monaco et al. 23
13 Direct demonstration of the active salvage of preformed purines by murine tumors Biochemical and Biophysical Research Communications Dana L. Johnson, Robert J. Mullin et al. 1
14 Clinical experience with leucovorin and 5-fluorouracil Cancer Leslie R. Laufman, Wayne D. Brenckman et al. 23
15 Folate analogs. 32. Synthesis and biological evaluation of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid and related compounds Journal of Medicinal Chemistry Muraleedharan G. Nair, John Galivan et al. 22
16 Folate analogs. 31. Synthesis of the reduced derivatives of 11-deazahomofolic acid, 10-methyl-11-deazahomofolic acid, and their evaluation as inhibitors of glycinamide ribonucleotide formyltransferase Journal of Medicinal Chemistry Muraleedharan G. Nair, Roy L. Kisliuk et al. 11
17 In vivo measurement of dihydrofolate reductase and its inhibition by antifolates Analytical Biochemistry David S. Duch et al. 2
18 Biosynthesis of tetrahydrobiopterin in the presence of dihydrofolate reductase inhibitors. Molecular Pharmacology David S. Duch, Mark Edelstein et al. 23
19 Inhibition of Histamine-Metabolizing Enzymes and Elevation of Histamine Levels in Tissues by Lipid-Soluble Anticancer Folate Antagonists Molecular Pharmacology David S. Duch, Mark Edelstein et al. 39
20 Dihydrofolate reductase in primary brain tumors, cell cultures of central nervous system origin, and normal brain during fetal and neonatal growth. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) David S. Duch, Darell D. Bigner et al. 13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026